Attached files
file | filename |
---|---|
EX-10.1 - SHARE EXCHANGE AGREEMENT - HEALTH ADVANCE INC. | hadv_ex101.htm |
8-K - CURRENT REPORT - HEALTH ADVANCE INC. | hadv_8k.htm |
Exhibit
99.1
Health Advance Inc. Announces Signing of Definitive Agreement to
Acquire Hantian Labs
LAS
VEGAS, October 14, 2016 – Health Advance Inc. (the
“Company”) (OTC Pinks: HADV) is pleased to announce
that on October 13, 2016, the Company signed a definitive agreement
(“Definitive Agreement”) to acquire 100% interest in
Hantian Labs Limited, a private UK corporation (Hereinafter
referred to as “Hantian”). As a result of the
acquisition, Health Advance will also control 99% of JT Hantian LLC
representing the revenue arm of Hantian. Pursuant to the Definitive
Agreement, on closing the Health Advance will issue 1.5 common
shares of the Company for each share of Hantian Labs outstanding at
the time of closing representing the purchase price of Hantian.
Accordingly, the Company’s issued and outstanding number of
common shares will increase from 24,520,000 shares to 39,520,000
shares. In addition, Hantian shall undertake to raise a minimum
financing of $250,000 for marketing of Hantian’s product line
prior to the closing of the transaction.
On
closing the Company will appoint Mr. Christian Diesveld as a
director of Health Advance. Mr. Diesveld is currently the Managing
Director of Hantian. Prior to co-founding Hantian Labs, Christian
spent a total of sixteen years within the public marketplace,
specializing in the marketing and financing of exchange-listed
companies to all facets of the international investment community.
Additionally, Mr. Diesveld spent the previous ten years in the role
of Managing Director at Peritus Capital, a Toronto based Investor
Relations firm. Having worked closely with corporations in the
pharmaceutical, technology and resource sectors, Christian brings
an abundance of experience and contacts from a wide range of
sectors throughout the global marketplace.
Hantian
Labs (www.hantianlabs.com) is an
emerging global leader in anti-ageing and vitality nutraceutical
products. Developed by a team of research scientists, athletes and
beauty professionals, the Hantian line of tablets uses
state-of-the-art age reversal technology to diminish the signs of
ageing, whilst enhancing, enriching and extending the lives of
their consumers. Products, including GHBurn, Alpha Elite and
Revitamar, are made at Hantian’s GMP ISO 9001 and Informed
Sports certified facility in the United Kingdom with the strictest
quality standards. Hantian products are Medicines & Healthcare
Products Regulatory Agency (MHRA) approved. Hantian also has
licenses issued by the Minister of Health for Canada, issued under
the authority of section 7 of the Natural Health Products
Regulations, for its products GHBurn and Alpha Elite.
GHBurn is a scientifically proven powerful natural precursor to HGH
(Human Growth Hormone), the body’s master hormone. It was
uniquely designed to enhance the body’s hormonal system,
which begins to deteriorate after the age of thirty. It increases
testosterone production, lean muscle mass, enhances energy,
alertness and libido, while decreasing fat production and cravings.
GHBurn provides muscles with increased energy at the cellular level
enhancing athletic performance and ability. Used daily, the unique
proprietary blend of ingredients regulates male hormones, which in
effect halts and more importantly reverses the aging
process.
Alpha Elite is widely considered one of the ultimate
supplements to combat natural
testosterone deterioration and enhance overall male performance. It
stimulates and intensifies all vigorous activity for the Alpha
Elite male. Being stimulant free, it safely elevates your
testosterone to new levels, whilst increasing your lean
muscularity, vascularity and libido.
Revitamar is a powerful age defying supplement proven to banish
wrinkles and restore a youthful appearance. The pioneering
restorative blend of antioxidants, minerals and marine properties
stimulates youthful radiant skin and softens fine lines. Founded in
the age old notion of ‘health through water’, the high
concentration of marine collagen and sea kelp naturally restore
elasticity, diminishes pigmentation and protect cells from
oxidative damage while hyaluronic acid, zinc and vitamin C, secures
moisture, creates fullness, decreases the appearance of cellulite
and alleviates joint pain.
“We
are eager to advance Health Advance through continued expansion.
The addition of Christian Diesveld to our board of directors brings
leadership, extensive financing experience, and vast knowledge of
the nutraceutical sector, all critical to our success,”
stated President and CEO,Jordan Starkman. “We are thrilled to
have entered into the nutraceutical sector and remain committed to
creating shareholder value for Health Advance’s
shareholders.
Certain statements in this document that are not historical facts
are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995. Such
statements may be identified by the use of words such as
“anticipate, “believe,” “expect,”
“future,” “may,” “will,”
“would,” “should,” “plan,”
“projected,” “intend,” and similar
expressions. Such forward-looking statements, involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of Health Advance Inc.
to be materially different from those expressed or implied by such
forward-looking statements. The Company’s future operating
results are dependent upon many factors, including but not limited
to: (i) the Company’s ability to obtain sufficient capital or
a strategic business arrangement to fund its current operational or
expansion plans; (ii) the Company’s ability to build and
maintain the management and human resources and infrastructure
necessary to support the anticipated growth of its business; (iii)
competitive factors and developments beyond the Company’s
control; and (iv) other risk factors discussed in the
Company’s periodic filings with the Securities and Exchange
Commission, which are available for review at www.sec.gov under “Search for Company
Filings.
For
more information, please contact:
Health
Advance Inc.
Jordan
Starkman, CEO
www.healthadvanceinc.com
1-800-854-7970
3651
Lindell Road, Suite D155, Las Vegas, NV 89103
1-800-854-7970